Leg Ulcers and Hydroxyurea
Marie-Emmanuelle Sirieix(Hôpital Broussais), J P Denoeux, C. Debure, G Lorette, S. Loubeyres, O Gauthier, C. Françès(Navarre Institute of Health Research), P Morel, B. Guillot(Université de Montpellier), N. Baudot, Donald H. Lambert(Boston Medical Center), P. Humbert, Louis Dubertret(Hôpital Saint-Louis), C. Lok(Centre Hospitalier Universitaire Amiens-Picardie), J.-M. Bonnetblanc, L. Vaillant(Centre Hospitalier Universitaire de Tours), C Beylot(Université de Bordeaux), M Roux, M. Dandurand
Cited by 137
Related Papers
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
|The Lancet Oncology|2021|392
Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial
|European Journal of Cancer|2017|284
Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas.
|PubMed|2000|267
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Skin Thickness Changes in Normal Aging Skin
|Gerontology|2009|258